cholestyramine resin has been researched along with prazosin in 3 studies
Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (prazosin) | Trials (prazosin) | Recent Studies (post-2010) (prazosin) |
---|---|---|---|---|---|
2,669 | 342 | 190 | 7,914 | 713 | 682 |
Protein | Taxonomy | cholestyramine resin (IC50) | prazosin (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Homo sapiens (human) | 5.87 | |
Interstitial collagenase | Homo sapiens (human) | 4.036 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.638 | |
Matrix metalloproteinase-9 | Homo sapiens (human) | 6.963 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.0078 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.29 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.647 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0007 | |
Bromodomain-containing protein 2 | Homo sapiens (human) | 0.0009 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0006 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0006 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 4.118 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | 9.9 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.5849 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Durham, SK; Kowala, MC; Nicolosi, RJ; Nunnari, JJ | 1 |
Swindell, AC; Valentine, JJ | 1 |
Grimm, RH; Hunninghake, DB | 1 |
3 other study(ies) available for cholestyramine resin and prazosin
Article | Year |
---|---|
Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters.
Topics: Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Cholesterol; Cholestyramine Resin; Cricetinae; Doxazosin; Heart Rate; Hyperlipidemias; Lipoproteins; Male; Mesocricetus; Prazosin | 1991 |
Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Disease Models, Animal; Doxazosin; Female; Hypercholesterolemia; Lipoproteins; Male; Mice; Mice, Inbred Strains; Prazosin | 1987 |
Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Coronary Disease; Diet Therapy; Diuretics; Female; Humans; Hypertension; Lipid Metabolism; Lipids; Lipoproteins; Male; Prazosin; Risk; Smoking | 1986 |